Multidrug-resistant tuberculosis in migrants, multi-country cluster - 3rd update, 13 April 2017
A multi-country cluster of multidrug-resistant tuberculosis (MDR TB) involving 28 migrants has been delineated by whole genome sequencing (WGS) in migrants recently having arrived from countries in the Horn of Africa.
Rapid risk assessment: multidrug-resistant tuberculosis in migrants, multi-country cluster - 2nd update, 27 March 2017
This second update provides information regarding the risk of EU transmission of an MDR TB clone initially detected in seven asylum seekers from the Horn of Africa who currently reside in Switzerland.
Rapid risk assessment: Shigellosis among refugees in the EU, 30 November 2015
The occurrence of shigellosis among refugees is not unexpected because shigellosis is endemic in the countries they originate from, as well as in some of the countries they travel through.
Rapid risk assessment: Communicable disease risks associated with the movement of refugees in Europe during the winter season, 16 November 2015
This risk assessment focuses on the threat to the refugee population from communicable diseases and assesses the situation in Europe, associated with the current movements of refugees across the region and in the context of their living conditions and the approaching winter, access to shelter, sanitation and health services.
Risk of importation and spread of malaria and other vector-borne diseases associated with the arrival of migrants to the EU, 22 October 2015
This rapid risk assessment assesses the specific risk related to importation and spread of vector borne diseases in the context of a large number of migrants to the EU. It does not cover other health needs for these populations.
Rapid risk assessment: Cutaneous diphtheria among recently arrived refugees and asylum-seekers in the EU, 31 July 2015
This rapid risk assessment concludes that there is currently no indication that these cases represent a significant outbreak of diphtheria among refugees in Europe.
Rapid risk assessment: Louse-borne relapsing fever in the Netherlands, 27 July 2015
Following reports from the Netherlands of two cases of louse-borne relapsing fever in asylum seekers coming from Eritrea, ECDC has assessed the risk to Europe.
Risk of introduction and transmission of wild-type poliovirus in EU/EEA countries following events in Israel and Syria – updated risk assessment (9 December 2013)
The confirmed circulation of wild-type poliovirus (WPV) in Israel and the outbreak of poliomyelitis in Syria mean that there is a high risk the disease will be reintroduced into the EU/EEA.
Suspected outbreak of poliomyelitis in Syria: Risk of importation and spread of poliovirus in the EU
Following the announcement by WHO of a cluster of cases of acute flaccid paralysis in Syria, ECDC conducted a risk assessment and concludes that this does pose a risk that polio might be imported to the EU. The Risk Assessment includes number of recommendations for EU Member States.
Joint ECDC and EMCDDA rapid risk assessment: HIV in injecting drug users in the EU/EEA, following a reported increase of cases in Greece and Romania
Most European countries reported no changes in the rate of newly diagnosed cases of HIV or HIV prevalence in IDU in 2011.